terodiline has been researched along with (4-(m-chlorophenylcarbamoyloxy)-2-butynyl)trimethylammonium chloride in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Enna, SJ; Lowe, VC; Noronha-Blob, L; Prosser, JC; Sturm, BL | 1 |
1 other study(ies) available for terodiline and (4-(m-chlorophenylcarbamoyloxy)-2-butynyl)trimethylammonium chloride
| Article | Year |
|---|---|
(+/-)-Terodiline: an M1-selective muscarinic receptor antagonist. In vivo effects at muscarinic receptors mediating urinary bladder contraction, mydriasis and salivary secretion.
Topics: (4-(m-Chlorophenylcarbamoyloxy)-2-butynyl)trimethylammonium Chloride; Animals; Atrial Function; Butylamines; Electric Stimulation; Female; Guinea Pigs; In Vitro Techniques; Male; Muscarinic Antagonists; Muscle Contraction; Muscle, Smooth; Mydriatics; Myocardial Contraction; Parasympatholytics; Pirenzepine; Pupil; Rabbits; Receptors, Muscarinic; Salivation; Urinary Bladder; Vas Deferens | 1991 |